
Doug Schenkel
Stock Analyst at UBS
(4.95)
# 130
Out of 5,136 analysts
429
Total ratings
65%
Success rate
25.7%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TWST Twist Bioscience | Maintained: Hold | $60 → $120 | $111.60 | +7.53% | 5 | Nov 16, 2026 | |
| HTFL HeartFlow | Reiterated: Hold | $60 | $48.46 | +23.81% | 1 | Nov 16, 2026 | |
| QGEN Qiagen | Rated: Hold | $50 | $49.89 | +0.22% | 26 | Nov 13, 2026 | |
| PACB Pacific Biosciences of California | Rated: Hold | $2.7 | $1.96 | +37.76% | 7 | Nov 9, 2026 | |
| TXG 10x Genomics | Rated: Hold | $68 → $61 | $58.19 | +4.83% | 11 | Nov 9, 2026 | |
| VCYT Veracyte | Rated: Buy | $65 → $35 | $24.33 | +43.86% | 3 | Nov 9, 2026 | |
| STVN Stevanato Group | Reiterated: Hold | $23 → $16 | $15.80 | +1.27% | 3 | Nov 4, 2026 | |
| TEM Tempus AI | Reiterated: Hold | $70 → $80 | $71.60 | +11.73% | 3 | Nov 2, 2026 | |
| WST West Pharmaceutical Services | Reiterated: Buy | $415 → $495 | $416.42 | +18.87% | 3 | Oct 30, 2026 | |
| RGEN Repligen | Reiterated: Buy | $225 → $235 | $167.79 | +40.06% | 5 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 → $260 | $233.02 | +11.58% | 25 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $730 → $800 | $700.22 | +14.25% | 23 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $165 → $180 | $173.96 | +3.47% | 36 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $175 | $115.89 | +51.01% | 4 | Oct 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | 300p | 238p | +26.16% | 1 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $225 | $151.70 | +48.32% | 9 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $150 → $260 | $207.01 | +25.60% | 40 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 → $435 | $319.09 | +36.33% | 18 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $480 → $490 | $460.25 | +6.46% | 23 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $60 | $61.59 | -2.58% | 20 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $15.54 | n/a | 7 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $23.04 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.66 | n/a | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1,738.91 | n/a | 1 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | €265.00 | €290.50 | n/a | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $7.54 | n/a | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $154.39 | n/a | 25 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $8.21 | n/a | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $8.45 | n/a | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.01 | n/a | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | - | n/a | 2 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $25 | $1.16 | n/a | 7 | Jul 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $26 | $4.13 | n/a | 5 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $9.74 | n/a | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.57 | n/a | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $540 | $83.33 | n/a | 25 | Sep 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $13.29 | n/a | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $90 | $20.07 | n/a | 18 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $4 | $0.7074 | n/a | 14 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $29.04 | n/a | 1 | Jul 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $15.71 | n/a | 1 | Jul 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $152.48 | n/a | 15 | Mar 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 → $275 | $218.03 | n/a | 12 | Aug 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.93 | n/a | 1 | Jan 2, 2018 |
Twist Bioscience
Nov 16, 2026
Maintained: Hold
Price Target: $60 → $120
Current: $111.60
Upside: +7.53%
HeartFlow
Nov 16, 2026
Reiterated: Hold
Price Target: $60
Current: $48.46
Upside: +23.81%
Qiagen
Nov 13, 2026
Rated: Hold
Price Target: $50
Current: $49.89
Upside: +0.22%
Pacific Biosciences of California
Nov 9, 2026
Rated: Hold
Price Target: $2.7
Current: $1.96
Upside: +37.76%
10x Genomics
Nov 9, 2026
Rated: Hold
Price Target: $68 → $61
Current: $58.19
Upside: +4.83%
Veracyte
Nov 9, 2026
Rated: Buy
Price Target: $65 → $35
Current: $24.33
Upside: +43.86%
Stevanato Group
Nov 4, 2026
Reiterated: Hold
Price Target: $23 → $16
Current: $15.80
Upside: +1.27%
Tempus AI
Nov 2, 2026
Reiterated: Hold
Price Target: $70 → $80
Current: $71.60
Upside: +11.73%
West Pharmaceutical Services
Oct 30, 2026
Reiterated: Buy
Price Target: $415 → $495
Current: $416.42
Upside: +18.87%
Repligen
Oct 28, 2026
Reiterated: Buy
Price Target: $225 → $235
Current: $167.79
Upside: +40.06%
Oct 22, 2026
Reiterated: Buy
Price Target: $250 → $260
Current: $233.02
Upside: +11.58%
Oct 22, 2026
Reiterated: Buy
Price Target: $730 → $800
Current: $700.22
Upside: +14.25%
Oct 14, 2026
Reiterated: Hold
Price Target: $165 → $180
Current: $173.96
Upside: +3.47%
Oct 2, 2026
Reiterated: Buy
Price Target: $105 → $175
Current: $115.89
Upside: +51.01%
Sep 9, 2026
Initiated Coverage: Hold
Price Target: 300p
Current: 238p
Upside: +26.16%
Sep 9, 2026
Reiterated: Buy
Price Target: $75 → $225
Current: $151.70
Upside: +48.32%
Sep 9, 2026
Upgraded: Buy
Price Target: $150 → $260
Current: $207.01
Upside: +25.60%
Sep 9, 2026
Reiterated: Buy
Price Target: $135 → $435
Current: $319.09
Upside: +36.33%
Sep 9, 2026
Upgraded: Buy
Price Target: $480 → $490
Current: $460.25
Upside: +6.46%
Dec 10, 2025
Upgraded: Buy
Price Target: $60
Current: $61.59
Upside: -2.58%
Jul 21, 2025
Reiterated: Hold
Price Target: n/a
Current: $15.54
Upside: n/a
Jul 14, 2025
Initiated Coverage: Buy
Price Target: $32
Current: $23.04
Upside: n/a
May 7, 2025
Downgraded: Hold
Price Target: n/a
Current: $5.66
Upside: n/a
Dec 13, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $1,738.91
Upside: n/a
Nov 14, 2024
Initiated Coverage: Buy
Price Target: €265.00
Current: €290.50
Upside: n/a
Nov 14, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $7.54
Upside: n/a
Dec 12, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $154.39
Upside: n/a
Aug 17, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $8.21
Upside: n/a
Aug 16, 2021
Initiated Coverage: Hold
Price Target: n/a
Current: $8.45
Upside: n/a
Aug 9, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $2.01
Upside: n/a
Aug 4, 2021
Downgraded: Hold
Price Target: n/a
Current: -
Upside: n/a
Jul 1, 2021
Reiterated: Buy
Price Target: $18 → $25
Current: $1.16
Upside: n/a
Mar 17, 2021
Reiterated: Buy
Price Target: $17 → $26
Current: $4.13
Upside: n/a
Jan 12, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $9.74
Upside: n/a
Dec 29, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $1.57
Upside: n/a
Sep 28, 2020
Reiterated: Buy
Price Target: $540
Current: $83.33
Upside: n/a
Jul 7, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $13.29
Upside: n/a
Feb 25, 2020
Reiterated: Buy
Price Target: $85 → $90
Current: $20.07
Upside: n/a
Jan 6, 2020
Reiterated: Hold
Price Target: $10 → $4
Current: $0.7074
Upside: n/a
Jul 22, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $29.04
Upside: n/a
Jul 15, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $15.71
Upside: n/a
Mar 20, 2019
Reiterated: Buy
Price Target: $110
Current: $152.48
Upside: n/a
Aug 2, 2018
Reiterated: Buy
Price Target: $250 → $275
Current: $218.03
Upside: n/a
Jan 2, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $2.93
Upside: n/a